Daxor Announces Saint Luke's Hospital of Bethlehem, PA Acquires Second Blood Volume Analyzer BVA-100
Posted on: Tuesday, 12 June 2007, 10:53 CDT
Daxor Corporation (AMEX: DXR), a medical instrumentation and biotechnology company, today announced the receipt of a signed trial agreement for a second Blood Volume Analyzer BVA-100 from Saint Luke's Hospital of Bethlehem, Pennsylvania. Following the purchase of their first BVA-100, Saint Luke's Hospital decided to acquire a second BVA-100 for their Allentown, Pennsylvania location. Saint Luke's Hospital is a non-profit, tertiary-care, teaching hospital with campuses located in Bethlehem, Allentown and Quakertown, Pennsylvania.
Saint Luke's Hospital is a fully accredited Level I trauma center, offering the region's most honored open-heart surgery program and the Saint Luke's Regional Heart Center, ranked as one of the nation's Best Heart Hospitals by U.S. News & World Report for seven consecutive years (1999-2005). Saint Luke's Hospital has also been recognized with awards in "100 Top Cardiovascular Hospitals" and the "100 Top ICU Hospitals." Following the purchase of their first BVA-100, Saint Luke's Hospital's Nuclear Medicine Department realized a need for a second BVA-100 for their Allentown location to respond to the clinical requirements of a major expansion and implementation of a new cardiovascular program.
Like Saint Luke's Hospital, many institutions and their patients have benefited from the use of Daxor's BVA-100 to diagnose and guide therapy in the treatment of a patient's blood volume. An upcoming symposium publication in a nationally recognized, peer-reviewed publication is scheduled for publication next month. The symposium publication will report on many clinical uses of a blood volume analysis in the diagnosis and treatment of various disease states with volume abnormalities. Various researchers will report on their use of Daxor's BVA-100 and the results of their respective clinical studies.
Other nationally renowned hospitals which have purchased the BVA-100 Blood Volume Analyzer after using it on a clinical trial basis are The Mayo Clinic, The Cleveland Clinic, and New York University Medical Center. Daxor Corporation manufactures and markets the BVA-100, a semi-automated Blood Volume Analyzer. The BVA-100 is used in conjunction with Volumex, Daxor's single use diagnostic kit. For more information regarding Daxor Corporation's Blood Volume Analyzer BVA-100, visit Daxor's website www.Daxor.com.
Contact Information: Stephen Feldschuh Chief Operating Officer 212-330-8515 Email Contact Diane Meegan Investor Relations 212-330-8512 Email Contact
SOURCE: Daxor Corp.
Source: MARKET WIRE
Related Articles
- Supplier Added to Premier Agreements for Blood Gas Analyzers, Reagents, Consumables and Service
- Hospitals, Healthcare Providers to Save With Premier Agreements for Blood Gas Analyzers, Reagents, Consumables, and Service
- MedCath Announces Completion of Sale of Dayton Heart Hospital to Good Samaritan Hospital-Dayton
- First Prostate Cancer Patients Treated in a Phase I Clinical Trial As Part of a Collaboration Between Generex Biotechnology and the Saint Savas Cancer Hospital
- J.D. Power and Associates Reports: Norton Hospital and Norton Suburban Hospital Recognized for Providing an 'Outstanding Inpatient Experience'
- DomaniCell Launches Hospital-Based Cord Blood Banking Business; Company Provides Hospitals With Turnkey Cord Blood Banking Program
- Hillcrest System to End Hospital Pacts: Four Area Hospitals Are Affected, Including Wago- Ner Community Hospital.
- Saint Francis Physician Hospital Organization Selects Allscripts
- Six Hospitals to Receive Grants to Analyze Hospital-Acquired Infections
- Lakeside Hospital Becomes Tulane-Lakeside Hospital After Merging of Services
 |
 |
User Comments (0)
RSS Feeds